These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 5568682)

  • 1. [Activating component in the effect of tranquilizing agents of the benzdiazepin series].
    Vikhliaev IuI; Klygul' TA
    Farmakol Toksikol; 1971; 34(3):268-72. PubMed ID: 5568682
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparison of the characteristics of the effect of tranquilizing agents under experimental and clinical conditions].
    Vikhliaev IuI; Klygul' TA; Prokudin VN; Adronati SA
    Farmakol Toksikol; 1971; 34(1):30-5. PubMed ID: 5563373
    [No Abstract]   [Full Text] [Related]  

  • 3. [Relation between anticorazol and antiamidopyrine effect of minor tranquilizing agents].
    Kuzina NV
    Farmakol Toksikol; 1970; 33(2):159-63. PubMed ID: 4393232
    [No Abstract]   [Full Text] [Related]  

  • 4. Neuropharmacological properties of Su17595A a chlorpromazine-like central nervous system depressant.
    Wilson DE; Chernov HI; Bernard PS; Partyka DA; Barbaz BS; DeStevens G
    Arch Int Pharmacodyn Ther; 1971 May; 191(1):15-23. PubMed ID: 5557392
    [No Abstract]   [Full Text] [Related]  

  • 5. [Animal experimental comparison of tranquilizing effect of doxepine with known psychopharmaceuticals].
    Wohlfarth-Ribbentrop A; Schaumann W
    Arzneimittelforschung; 1969 Dec; 19(12):2012-5. PubMed ID: 5395895
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pharmacologic differentiation of sedatives].
    Dixon K; Taeschler M
    Rev Neurol (Paris); 1969 Jun; 120(6):389-91. PubMed ID: 5379316
    [No Abstract]   [Full Text] [Related]  

  • 7. [Differentiation of neuroleptic and psychosedative effects in screening].
    Ott T; Matthies H
    Acta Biol Med Ger; 1969; 22(5):815-8. PubMed ID: 5392750
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of aziprine on the central nervous system].
    Ponomareva AG
    Farmakol Toksikol; 1969; 32(4):403-6. PubMed ID: 5357457
    [No Abstract]   [Full Text] [Related]  

  • 9. [Modification of the alcohol effect by valepotriate].
    von Eickstedt KW
    Arzneimittelforschung; 1969 Jun; 19(6):995-7. PubMed ID: 5820046
    [No Abstract]   [Full Text] [Related]  

  • 10. A potential screening test for minor tranquilizing drug action.
    Morrison CF
    Br J Pharmacol; 1970 Feb; 38(2):460P. PubMed ID: 5417886
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of tranquilizing and antidepressive agents on the summation of impulses in the central nervous system].
    Zakusov VV
    Farmakol Toksikol; 1971; 34(1):7-9. PubMed ID: 4327456
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacological properties of substituted gamma-butyrolactones. I. The effects on the central nervous system.
    Sieroslawska J; Hano J; Sypniewska M; Czarnecki R; Chojnacka-Wójcik E; Harasiewicz A
    Pol J Pharmacol Pharm; 1973; 25(1):1-16. PubMed ID: 4798097
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of alpha- and beta-adrenoblocking agents on some central effect of phenamine].
    Gura CIa; Raevskiĭ KS
    Farmakol Toksikol; 1970; 33(3):267-71. PubMed ID: 4393829
    [No Abstract]   [Full Text] [Related]  

  • 14. Letter: Prescribing hypnotic and anti-anxiety drugs.
    Maronde RF; Silverman M
    Ann Intern Med; 1973 Sep; 79(3):452-3. PubMed ID: 4748265
    [No Abstract]   [Full Text] [Related]  

  • 15. [2-ethylamino-6-chloro-4-methyl-4-phenyl-4H-3,1-benzoxazine, a new psychotropic compound].
    Hoffmann I; Kuch H; Schmitt K; Seidl G
    Arzneimittelforschung; 1970 Jul; 20(7):975. PubMed ID: 5536073
    [No Abstract]   [Full Text] [Related]  

  • 16. [Driving tests to determine the influence of alcohol, tranquilizers and hypnotics on driing capability].
    Kielholz P; Goldberg L; Obersteg JI; Pöldinger W; Ramseyer A; Schmid P
    Dtsch Med Wochenschr; 1969 Feb; 94(7):301-6. PubMed ID: 5762987
    [No Abstract]   [Full Text] [Related]  

  • 17. Potentiation of jumping behavior by aminophylline in mice treated with threshold doses of amphentamine and dopa.
    Colpaert FC; Lal H
    Res Commun Chem Pathol Pharmacol; 1974 Nov; 9(3):587-90. PubMed ID: 4445575
    [No Abstract]   [Full Text] [Related]  

  • 18. Persistence of dose related behavior in mice.
    Dorr M; Joyce D; Steinberg H; Summerfield A; Tomkiewicz M
    Br J Pharmacol; 1970 May; 39(1):208P-209P. PubMed ID: 5420105
    [No Abstract]   [Full Text] [Related]  

  • 19. Development of a home cage locomotor tracking system capable of detecting the stimulant and sedative properties of drugs in rats.
    Dunne F; O'Halloran A; Kelly JP
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct; 31(7):1456-63. PubMed ID: 17706334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of psychotropic substances on the behavior of cats, induced by administration of acetylcholine into the hypothalamus].
    Kurochkin IG; Burov IuV
    Farmakol Toksikol; 1971; 34(1):21-5. PubMed ID: 5563371
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.